Coherus BioSciences (CHRS) Commences $125M Offering of Common Stock
Tweet Send to a Friend
Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced it has commenced an underwritten public offering of $125,000,000 of shares of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
